China SXT Pharmaceuticals, Inc. (SXTC) Gross profit 2017–2026
China SXT Pharmaceuticals, Inc. (SXTC) annual gross profit history from SEC filings — each fiscal year as reported.
$248,702FY2026 · since FY2017: $2.3M → $248,702
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $248,702 | -32.3% |
| FY2025 | $367,427 | -33.7% |
| FY2024 | $553,971 | +30.0% |
| FY2023 | $426,271 | -65.9% |
| FY2022 | $1.3M | -55.9% |
| FY2021 | $2.8M | +5.0% |
| FY2020 | $2.7M | -41.4% |
| FY2019 | $4.6M | +35.6% |
| FY2018 | $3.4M | +47.1% |
| FY2017 | $2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice